Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

AngloGold Ashanti Limited (ADR) (AU): Hendge Funds Are Buying, Should You?

As we already know from media reports and hedge fund investor letters, many hedge funds lost money in the third quarter, blaming macroeconomic conditions and unpredictable events that hit several sectors, with healthcare among them. Nevertheless, most investors decided to stick to their bullish theses and their long-term focus allows us to profit from the recent declines. In particular, let’s take a look at what hedge funds think about AngloGold Ashanti Limited (ADR) (NYSE:AU) in this article.

AngloGold Ashanti Limited (ADR) (NYSE:AU) was in 15 hedge funds’ portfolios at the end of September. AngloGold Ashanti Limited (ADR) (NYSE:AU) has seen a decrease in hedge fund sentiment of late. There were 18 hedge funds in our database with AngloGold Ashanti Limited (ADR) (NYSE:AU) holdings at the end of the previous quarter. At the end of this article, we will also compare AngloGold Ashanti Limited (ADR) (NYSE:AU) to other stocks, including American Capital Ltd. (NASDAQ:ACAS), RLJ Lodging Trust (NYSE:RLJ), and Webster Financial Corporation (NYSE:WBS) to get a better sense of its popularity.

Follow Anglogold Ashanti Ltd (NYSE:AU)
Trade (NYSE:AU) Now!

In the eyes of most traders, hedge funds are seen as worthless, outdated investment vehicles of yesteryear. While there are more than 8000 funds trading today, We choose to focus on the crème de la crème of this club, approximately 700 funds. These money managers shepherd most of the smart money’s total capital, and by shadowing their highest performing equity investments, Insider Monkey has unearthed a few investment strategies that have historically beaten the broader indices. Insider Monkey’s small-cap hedge fund strategy exceeded the S&P 500 index by 12 percentage points a year for a decade in their back tests.

With all of this in mind, we’re going to take a glance at the recent action encompassing AngloGold Ashanti Limited (ADR) (NYSE:AU).

How have hedgies been trading AngloGold Ashanti Limited (ADR) (NYSE:AU)?

Heading into Q4, a total of 15 of the hedge funds tracked by Insider Monkey were long this stock, a decline of 17% from one quarter earlier. With hedgies’ sentiment swirling, there exists a select group of noteworthy hedge fund managers who were boosting their holdings meaningfully (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, John Paulson’s Paulson & Co has the number one position in AngloGold Ashanti Limited (ADR) (NYSE:AU), worth close to $205 million, corresponding to 1.1% of its total 13F portfolio. On Paulson & Co’s heels is Passport Capital, managed by John Burbank, which holds a $44 million position; the fund has 0.8% of its 13F portfolio invested in the stock. The remaining members of the smart money that are bullish contain Renaissance Technologies, Howard Marks’ Oaktree Capital Management, and Israel Englander’s Millennium Management.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.